Nathan Fielder's documentary featuring Elizabeth Holmes presents a carefully curated narrative that may overshadow the substantive elements of her fraud case. The production highlights Holmes's reinvention efforts, but critics argue this focus diverts attention from the legitimate concerns surrounding the Theranos scandal and its impact on investors and patients who relied on fraudulent technology claims.

Summary auto-generated by AI from the original publisher's content. Editorial standards.